US FDA approves KalVista Pharma's swelling disorder drug, shares rise - Reuters

Reuters | July 7, 2025, 8:22 a.m. | Original
US FDA approves KalVista Pharma's swelling disorder drug, shares rise Reuters
Mercedes-Benz Q2 sales fall 9% impacted by tariffs - Reuters CoreWeave to acquire crypto miner Core Scientific - Reuters